Navigation Links
US Patent Office rejects company's claim for bean commonly grown by Latin American farmers
Date:4/30/2008

hat covered any beans and hybrids derived from crosses with even one of his seeds.

Under USPTO rules, material published before a patent application that was not brought to the attention of the patent examiner can be used to reverse a granted claim. CIAT sought a reexamination of the Enola patent. The Food and Agriculture Organization (FAO) of the United Nations and ETC Group (formerly RAFI, the Rural Advancement Foundation International), a Canada-based nongovernmental organization dedicated to conservation and sustainable use of biodiversity, also denounced the Enola bean patent.

CIAT was able to dispute the inventors claims to a unique color by providing published evidence of 260 yellow beans among the almost 28,000 samples of Phaseolus in its crop genebank. At least six of the CIAT varieties were, to most observers, identical to the bean described in Proctors patent documents on the basis of color and genetic markers. CIAT also put forward publications to show that the claims in the patent application took credit for research already widely available in scientific literature and thus claims made regarding the breeding of the bean in his patent also failed to meet the patent offices statutory requirements for non-obviousness and novelty.

In addition, CIAT pointed out that Proctor had not obtained a permit to export the beans from Mexico and that a version of the bean variety in question had been released to the public by the Mexican government in the 1970s.

Yet Proctor actively enforced his patent. At one point, the patent-holders US$0.6-claim on every pound of yellow beans sold in the United States caused a steep decline in exports of such beans from Mexico to the USA, according to Mexican government sources.

The patent office issued a preliminary decision in 2003 rejecting all the patent claims and gave a final rejection in December 2005. Proctor filed an appeal through the USPTO, and in accordance with USPTO rul
'/>"/>

Contact: Ellen Wilson
ewilson@burnesscommunications.com
301-652-1558 ext. 5723
Burness Communications
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. bioMETRX, Inc. Acquires Patent for Biometric Padlock
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
4. Patent Issued for e-Smart Technologies, Inc.s First Biometric Match-on-Card Technology
5. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
6. Cornell patents a pink lily look-alike that blooms all summer long
7. Biotechnology needs 21st century patent system: Expert
8. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology
9. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
10. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
11. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/12/2015)... , Feb. 12, 2015   MedNet ... specializing in clinical study management systems, has recently ... , further distinguishing iMedNet ... Research Organizations (CROs) and healthcare consultants.  Building on ... prospective customer referrals and numerous co-marketing opportunities), MedNet,s ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... State University scientists believe they are the first in ... by probing individual bonds between an asbestos fiber and ... away, the researchers hope their findings could aid in ... to asbestos, including the deadly cancer called mesothelioma. ...
... the first time, researchers at the UCLA Henry Samueli ... nature beyond its limits by genetically modifying Escherichia ... to produce unusually long-chain alcohols essential in the creation ... able to synthesize long-chain alcohols containing five carbon atoms," ...
... research team at Singapore,s Infocomm Research (I2R) has ... IV, 2008, in all three electroencephalogram (EEG) based ... announced on Dec. 12 at the international Neural ... The Singapore scientists designed the non-invasive BCI ...
Cached Biology News:Scientists study how asbestos fibers trigger cancer in human cells 2Scientists study how asbestos fibers trigger cancer in human cells 3Researchers push nature beyond its limits to create higher-density biofuels 2Singapore research team first place in Brain-Computer Interface contest 2
(Date:3/3/2015)... March 3, 2015  Rosa & Co. LLC, a ... and simulation research, today announced it has two posters ... for Clinical Pharmacology and Therapeutics meeting in ... Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... a poster describing a quantitative systems pharmacology approach for ...
(Date:3/3/2015)... 03, 2015 Genedata, a leading ... and life science research, today announced that Pfizer ... platform for use at Pfizer biopharma research and ... is supporting Pfizer’s global deployment and roll out ... for Therapeutic Innovation (CTI), and Pharmaceutical Sciences groups. ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Gene Therapy - ... , Gene therapy technologies are ... and cell therapy with genetically modified vectors. Gene ... and various routes of administration as well as ...
(Date:3/3/2015)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of ... on protecting the microbiome, announced today that Jeffrey Riley ... 27th Annual ROTH Conference being held on March 8-11, 2015 ... Dana Point, CA. Mr. Riley is ... p.m. (Pacific Time). A live webcast of Synthetic ...
Breaking Biology Technology:Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2
... N.J., April 23 Pharmacopeia,(Nasdaq: PCOP ), an ... therapeutics, today announced that the company plans to,release its ... 2008,after the close of market on Wednesday, May 7, ... at 5:00 p.m. EDT on the same day., ...
... ANGELES, April 23 Cord Blood America,Inc. (Pink ... preservation,company ( http://www.cordblood-america.com ) focused on bringing ... nationwide and internationally,today announced that it has been ... Angeles area by The Los Angeles Business Journal., ...
... Md., April 22 EntreMed, Inc.,(Nasdaq: ENMD ... treatment of cancer and inflammatory diseases, today,announced that ... seeking,stockholder approval for a reverse stock split at ... June 5, 2008. In light of recent gains ...
Cached Biology Technology:Pharmacopeia to Host First Quarter 2008 Financial Results Webcast and Conference Call 2Pharmacopeia to Host First Quarter 2008 Financial Results Webcast and Conference Call 3Cord Blood America in Top 20 in Los Angeles Area Biotech-Biomed Companies 2EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting 2EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting 3
... stabilizer is designed to stabilize the ... long-term storage. There are neither ... It is a convenient 10 times ... is superior to other traditional lyophilizing ...
... designed for stabilizing the coating biomolecules ... immunoassay development. It can stabilize ... and drying process and for long ... works as a blocking agent to ...
... is Tecans open platform for clinical diagnostic ... and performance in the clinical diagnostic and ... flexible barcode reading and sample traceability as ... system complies with the IVD-Directive* established in ...
... TC-3000 is one of the smallest thermal cyclers ... choice of either the 0.5ml (20 samples) or ... , Fast heating and cooling rate of ... and high performance Fast track programming with ...
Biology Products: